Evidence map›Paper›PMID 41103457›Full record

ArticleStatistics in biosciences2025

Weighted Brier Score - an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration.

Kehao Zhu, Yingye Zheng, Kwun Chuen Gary Chan

Abstract read
In one paragraph

Article in Statistics in biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Foundation Models Meet Medical Image Interpretation.Research (Washington, D.C.) · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kehao ZhuDepartment of Biostatistics, University of Washington, Seattle, 98195, WA, USA.
Yingye ZhengPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, 98019, WA, USA.
Kwun Chuen Gary ChanDepartment of Biostatistics, University of Washington, Seattle, 98195, WA, USA.

Funding

The Early Detection Research Network: Data Management and Coordinating CenterU24CA086368 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RUTH D ETZIONI, Ziding Feng · 2010 to 2026
$75.7M
Statistical Methods for Prospective Evaluation of BiomarkersR01CA236558 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZHENG, YINGYE · 2019 to 2024
$1.9M
NCI NIH HHS R01 CA236558NCI NIH HHS U24 CA086368
6 · The paper itself

Abstract

As advancements in novel biomarker-based algorithms and models accelerate their use in disease risk prediction, it is crucial to evaluate these models within the context of their intended clinical application. Prediction models output the absolute risk of disease; subsequently, patient counseling and shared decision-making are based on the estimated individual risk and cost-benefit assessment. The overall impact of the application is referred to as clinical utility, which received significant attention and desire to incorporate into model assessment lately. The classic Brier score is a popular measure of prediction accuracy; however, it is insufficient for effectively assessing clinical utility. To address this limitation, we propose a class of weighted Brier scores that aligns with the decision-theoretic framework of clinical utility. Additionally, we decompose the weighted Brier score into discrimination and calibration components, and we link the weighted Brier score to the

Indexed as

Brier scorecalibrationclinical utilityH measurerisk prediction model

Identifiers

PMID41103457
PMCPMC12523994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.